TYSABRI 300 mg, 1 vial of 15 ml
About This Opportunity
TranslatedThis tender is for the procurement of TYSABRI, specifically in the 300 mg dosage, supplied in a 15 ml vial. TYSABRI is a medication used for the treatment of certain autoimmune diseases, such as multiple sclerosis. The procurement requires adherence to strict pharmaceutical quality standards and regulatory compliance. The tender documents will detail the specific quantities, delivery schedules, and packaging requirements. This acquisition is essential for ensuring the continuity of treatment for patients requiring TYSABRI. Potential suppliers must demonstrate their ability to provide a reliable supply of this critical medication, meeting all specified pharmaceutical and logistical requirements.
This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Spain, Europe, this opportunity is open to firms and consortiums.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: SpanishTYSABRI 300 mg, 1 vial de 15 ml
Data provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on March 30, 2026. Last refreshed 109 days ago. Original language: Spanish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Servicio Navarro de Salud-Osasunbidea
Servicio Navarro de Salud-Osasunbidea has issued 77 procurement notices on BidsFactory, including 1 currently open and 41 awarded contracts. Activity concentrates in Health & Medical, Architecture & Engineering Services, and Environment & Climate. All notices are published for Spain. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: September 28, 2026.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in Spain. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to BIOGEN SPAIN, S.L.. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Servicio Navarro de Salud-Osasunbidea in Spain. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
BIOGEN SPAIN, S.L. was awarded the contract for €87,870. The figure reflects the value disclosed by the contracting authority in the award notice.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.